Meeting Highlights: Cardiovascular Research Technologies 2019

A supplement to Cardiology News. This supplement was sponsored by Chiesi USA, Inc.

News included in the supplement:

• Ultrathin stent loses advantage at 3 years
• Adjunctive devices for TAVR boost outcomes
• MI alert device shows predictive value
• Readmissions high post STEMI with cardiogenic shock
• Endovascular device sustains BP reductions
• Alcohol renal denervation safe for BP reduction

A supplement to Cardiology News. This supplement was sponsored by Chiesi USA, Inc.

News included in the supplement:

• Ultrathin stent loses advantage at 3 years
• Adjunctive devices for TAVR boost outcomes
• MI alert device shows predictive value
• Readmissions high post STEMI with cardiogenic shock
• Endovascular device sustains BP reductions
• Alcohol renal denervation safe for BP reduction

A supplement to Cardiology News. This supplement was sponsored by Chiesi USA, Inc.

News included in the supplement:

• Ultrathin stent loses advantage at 3 years
• Adjunctive devices for TAVR boost outcomes
• MI alert device shows predictive value
• Readmissions high post STEMI with cardiogenic shock
• Endovascular device sustains BP reductions
• Alcohol renal denervation safe for BP reduction